Citation 74660

UENO,M: AMEMIYA,M: SOMENO,T: MASUDA,T: IINUMA,H: NAGANAWA,H: HAMADA,M: ISHIZUKA,M: TAKEUCHI,T:. (1993). IC101, EXTRACELLULAR MATRIX ANTAGONIST PRODUCED BY STREPTOMYCES SP. MJ202-72F3. PRODUCTION, ISOLATION, STRUCTURE DETERMINATION AND BIOLOGICAL ACTIVITY.. 46(11)

Citation Details

TitleIC101, EXTRACELLULAR MATRIX ANTAGONIST PRODUCED BY STREPTOMYCES SP. MJ202-72F3. PRODUCTION, ISOLATION, STRUCTURE DETERMINATION AND BIOLOGICAL ACTIVITY.
AuthorsUENO,M: AMEMIYA,M: SOMENO,T: MASUDA,T: IINUMA,H: NAGANAWA,H: HAMADA,M: ISHIZUKA,M: TAKEUCHI,T:
Year1993
Volume46
Issue11

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Streptomyces albulus (STREPTOMYCETACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
STREPTOMYCES ANTIBIOTIC IC-101
None
2
CELL ADHESION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
3
CELL ADHESION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
4
CELL ADHESION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
5
CELL ADHESION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
6
CELL ADHESION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
7
LYMPHOCYTE PROLIFERATION INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
8
LYMPHOCYTE(B) SUPPRESSION
PHARMACOLOGY OF COMPOUND - IN VIVO
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
9
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
PHARMACOLOGY OF COMPOUND - IN VIVO
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC IC-101
STRONG ACTIVITY
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC IC-101
STRONG ACTIVITY
12
NEUROMUSCULAR TOXICITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
STREPTOMYCES ANTIBIOTIC IC-101
STRONG ACTIVITY
13
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
14
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
15
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
16
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
17
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
18
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
ACTIVE
19
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
20
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
21
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
22
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
23
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
24
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
25
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
26
ANTIBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
27
ANTIMYCOBACTERIAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
28
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
29
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
30
ANTIYEAST ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
31
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
32
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
33
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROSYNERGISM REPORTED FOR
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
34
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
35
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
36
ANTIFUNGAL ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)
STREPTOMYCES ANTIBIOTIC IC-101
INACTIVE
Show SPARQL Queries (1)